898. Effectiveness and Tolerability of DTG + 3TC in Clinical Practice: Evidence in PLHIV from Real-world Data

Lee Evitt(ViiV Healthcare (United Kingdom)), Annemiek de Ruiter(ViiV Healthcare (Spain)), Jean A van Wyk(ViiV Healthcare (United Kingdom)), Rahul Kumar(GlaxoSmithKline (India)), Diwakar Jha(GlaxoSmithKline (India)), Rahul Kamath(GlaxoSmithKline (India)), Daniel Parks(GlaxoSmithKline (United States))
Open Forum Infectious Diseases
November 1, 2021
10.1093/ofid/ofab466.1093
Cited by 2

Related Papers

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006
|AIDS|2008|582
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197